Approaching our 2018 Proteins & Antibodies Congress, we sat down with one of our distinguished speakers, Darko Skegro, Senior Team Leader from Novartis to talk about the industry, upcoming developments and technologies he thinks will have a big impact on this growing area of research. Darko’s work is focused on engineering therapeutic proteins, optimisation of antibodies and antibody-like molecules. He has a remarkable experience in the field that also includes innovation, IP and utilising new technologies.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies from our website More info